Navigation Links
Nebivolol Lowers Blood Pressure in African Americans With Stage I-II Hypertension as Demonstrated in a Study Published in the Journal of Clinical Hypertension
Date:11/1/2007

NEW YORK, Nov. 1 /PRNewswire-FirstCall/ -- Forest Laboratories, Inc. (NYSE: FRX) today announced the results of a double-blind, randomized, placebo-controlled clinical trial, published in the November 2007 issue of the Journal of Clinical Hypertension, which demonstrated that nebivolol significantly reduced sitting diastolic and systolic blood pressure used as monotherapy among African-American patients with stage I-II hypertension. The study also found that nebivolol was well tolerated in comparison to placebo, with a low incidence of traditional beta blocker side effects, such as fatigue, sexual dysfunction, and depression. In addition, nebivolol was not associated with adverse changes in blood lipids and glucose levels. Nebivolol, a novel beta blocker, is currently under review by the U.S. Food and Drug Administration for the treatment of hypertension.

African Americans have an increased prevalence of high blood pressure, develop elevated blood pressure earlier in life, and have higher rates of hypertension-related death from stroke, heart disease, and end-stage kidney disease. Although awareness of hypertension in African Americans has increased in recent years, their control rates (blood pressure <140/90 mm/Hg) remain low at approximately 30 percent.

"The findings of this study are important considering the excessive burden of high blood pressure in African Americans and the need for new treatment options," explains Elijah Saunders, MD, lead investigator of the study and professor of medicine and Head, Section of Hypertension at the University of Maryland School of Medicine. "Advances like this in the beta blocker class are particularly important because African Americans have an historically poor resp
'/>"/>

SOURCE Forest Laboratories, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Data Presented at ASH Demonstrate Nebivolol Lowers Blood Pressure as Long-Term Monotherapy and in Combination Therapy
2. Rapid Whole Blood Testing for Infectious Mononucleosis Antibodies
3. Blood Gas Analysis: The Pros and Cons of Point-Of-Care Testing
4. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
5. Bio-Matrix Scientifics Dr. ONeill Sees University of Pittsburghs Published Study on Culture Blood-Forming Stem Cells from Human Fat Tissue as Supporting Near Term Benefits of Banking Adipose (Fat) Derived Stem Cells
6. New Data from Multiple Studies Show Galvus Delivers Consistent and Robust Blood Sugar Control in Patients with Type 2 Diabetes
7. Hypertension Vaccine CYT006-AngQb Achieves Strong Blood Pressure Reduction During Important Early Morning Period When Most Adverse Cardiovascular Events Occur
8. Prexige Study Shows Significantly Less Impact on Blood Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled Hypertension
9. Lumiracoxib Study Showed Significantly Less Impact on Blood Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled Hypertension
10. Algeta Demonstrates Targeted Cancer-killing Potential of Novel Alpha Particle Linked Antibodies in Leading Medical Journal Blood
11. NCI Researchers Discover Genes That Are Turned on at High Levels in Tumor-associated Blood Vessels of Mice and Humans
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... BURLINGTON, Mass. , Sept. 22, 2014 Decision ... Chilean pharmaceutical market is expected to be worth $2 billion ... 11.3 percent over the next five years (to 2018). This ... growth of 4.8 percent in 2013 and 4.9 percent expected ... pharmaceutical landscape is small but highly competitive. The ...
(Date:9/22/2014)... 22, 2014 Research and Markets ... "Global Ablation Technologies (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, ... to their offering. On the ... technologies market has been divided into eight major ... hydrothermal, and hydromechanical ablation technologies. The light/laser ablation ...
(Date:9/22/2014)... 22, 2014  For many people experiencing issues ... facing the prospect of large, painful incisions and ... activities are also impacted, such as working, driving ... the problem, some patients even delay necessary treatment, ... lead to permanent damage for some conditions. ...
Breaking Medicine Technology:Despite Its Limited Size, Chile's Pharmaceutical Market Offers Growing Opportunity for Drug Industry 2Despite Its Limited Size, Chile's Pharmaceutical Market Offers Growing Opportunity for Drug Industry 3Global Ablation Technologies (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave) Market - Forecasts to 2019 2Global Ablation Technologies (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave) Market - Forecasts to 2019 3Phoenix Arizona Hand Doctor Develops Revolutionary New Surgery System, Eliminates Need for Large Incisions 2
(Date:9/23/2014)... Cubit Labs is pleased to announce ... Play Store. , The popular cross platform contact sharing ... this year, gleaning a solid 5 star rating in ... has never been so easy and I highly recommend ... steps." - CrackBerry.com, View full App review here: ...
(Date:9/23/2014)... PA (PRWEB) September 23, 2014 Rinovum ... home-use conception assistance device on the market cleared by ... in stores and online at http://www.storkotc.com . , ... dream of having a baby is delayed by infertility1 ... first step to optimize their chances to conceive. ...
(Date:9/23/2014)... by researchers from the University of Cambridge has found that ... childhood leaves a ,signature, in the brain. The results ... Cortex . , The researchers studied 80 adult men ... who did not. They found that language delay was associated ... regions, including the temporal lobe, insula, ventral basal ganglia, which ...
(Date:9/23/2014)... 2014 Névo takes a bold step ... and adding advanced activity tracking and phone notifications for ... distance, calories burned, and more. , http://www.nevowatch.com ... healthy habits in their busy lives to look and ... that produce healthy results, but until now, style played ...
(Date:9/23/2014)... Medicine in Motion (MIM) is proud to ... 711 W. 38th, Suite G4. After serving the area’s sports ... increased demand for MIM’s superior care led to the need ... extremely excited about bringing our high-quality brand of sports medicine ... in Motion. “We’ll continue to provide patients with the same ...
Breaking Medicine News(10 mins):Health News:YOUnify for Android is Now Available in the Google Play Store 2Health News:First-Ever Conception Assistance Device FDA-Cleared for Home Use Launches U.S. OTC Sales -- The Stork® OTC Delivers Hope to Millions Struggling to Conceive A Child 2Health News:First-Ever Conception Assistance Device FDA-Cleared for Home Use Launches U.S. OTC Sales -- The Stork® OTC Delivers Hope to Millions Struggling to Conceive A Child 3Health News:First-Ever Conception Assistance Device FDA-Cleared for Home Use Launches U.S. OTC Sales -- The Stork® OTC Delivers Hope to Millions Struggling to Conceive A Child 4Health News:Presence or absence of early language delay alters anatomy of the brain in autism 2Health News:Nevo changes the face of fitness wearables with an analogue watch combining activity tracking, phone notifications, and LED goal progress indicators for active lifestyles 2Health News:Nevo changes the face of fitness wearables with an analogue watch combining activity tracking, phone notifications, and LED goal progress indicators for active lifestyles 3Health News:Austin Sports Medicine Practice to Host Grand Opening Event for Second Location 2
... Creates New Opportunities for Expansion of HIFU Technology, ... (USHIFU), the,distributor and provider of non-invasive high intensity ... has completed the acquisition,of Focus Surgery, Inc. (FSI) ... Sonablate(R) 500, an image-guided acoustic ablation,device. This acquisition ...
... of today,s,announcement that Attorney General Mike Cox is filing ... Coalition for a Fair and,Competitive Insurance Market is calling ... Cross Blue Shield of Michigan (BCBSM) to use their,unfair ... insurance., "We were confident when we raised this ...
... 2 A Miami resident was,sentenced to 130 months ... the,Medicare program, Acting Assistant Attorney General Matthew Friedrich of,the ... the Southern,District of Florida announced today., Gustavo Smith, ... for,the Southern District of Florida by Judge Marcia G. ...
... could one day help tailor treatments to individual patients, study ... technique for finding and analyzing stray cancer cells in the ... doctors to one day not only determine the genetic "signature" ... and adjust treatments accordingly. , "I think this is ...
... QC, July 2 /PRNewswire-FirstCall/ - Labopharm Inc. (TSX: ... a complete response to,the Food and Drug Administration ... the FDA,s Deputy Director, Center for Drug Evaluation,and ... regulatory path towards,potential U.S. approval of the Company,s ...
... July 2, 2008 -- Compact, bedside brain-activity monitors ... Washington University School of Medicine in St. Louis ... clinicians in monitoring for electrical seizures until confirmation ... an article published in the June issue of ...
Cached Medicine News:Health News:USHIFU, LLC Completes Acquisition of Focus Surgery, Inc. 2Health News:Coalition Calls on MI Legislature to Abandon Blue Cross Legislation 2Health News:Owner of Medical Equipment Company Sentenced to 130 Months in Prison for Health Care Fraud 2Health News:Owner of Medical Equipment Company Sentenced to 130 Months in Prison for Health Care Fraud 3Health News:Circulating Tumor Cells Reveal Insights Into Lung Cancers 2Health News:Circulating Tumor Cells Reveal Insights Into Lung Cancers 3Health News:Labopharm Submits Complete Response to FDA as a Result of Outcome of Appeal Process for Once-Daily Tramadol 2Health News:Seizures in newborns can be detected with small, portable brain activity monitors 2Health News:Seizures in newborns can be detected with small, portable brain activity monitors 3
Li Brand™ Surgical Hemostat. ("dissecting clamp") For NSV and other procedures....
... The 2201 is ideal for applications ... application of heat. , ,The autoclavable ... assortment of reusable thermal cautery electrodes, ... flexibility to perform a wide variety ...
No Scalpel Vasectomy Hemostat 5 1/2" (14cm), smooth sharp point, curved, gold finger rings...
Li Brand™ Ringed Forceps. ("fixation clamp") For NSV and other procedures. Ring diameter approximately 3.5 mm. Manufactured exclusively for AMI to exacting specifications by a German company....
Medicine Products: